David L. Hachey
Argonne National Laboratory
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David L. Hachey.
Life Sciences | 1979
Mary Jeanne Kreek; David L. Hachey; Peter D. Klein
Abstract Stable isotope labeled methadone (pentadeuteromethadone) has been used in conjunction with gas chromatography-chemical ionization mass spectrometry to study plasma disappearance rates and urinary excretion of pharmacologically active R-(−)-methadone (l-methadone) and inactive S-(+)-methadone (d-methadone) in three adult methadone maintenance patients. In all three cases, the analgesically active enantiomeric form of the drug had a significantly longer elimination half-life ( t 1 2 β ) when studied in a steady state than did the inactive form ( t 1 2 β for active R-(−)-methadone, 51.7 to 61.8 hours; t 1 2 β for inactive S-(+)-methadone, 31.8 to 37.0 hours). The ratio of drug elimination half-lives } R-(−)-/S-(+)- ranged between 1.40 and 1.94. In the two cases so studied, slower plasma disappearance of active R-(−)-enatiomer than the inactive S-(+)-enantiomer was also observed ( t 1 2β R-(−)-, 42.8 and 52.5 hours; t 1 2β S-(+)-, 38.3 and 41.3 hours).
Analytical Biochemistry | 1978
Frans Stellaard; David L. Hachey; Peter D. Klein
Abstract Bile acids have been separated by high-pressure liquid chromatography. The free acids were derivatized to their phenacyl esters by treatment with triethylamine and α-bromoacetophenone. The stationary phase was a C 18 , Partisil ODS column. A dual-solvent, stepwise gradient system was used for the mobile phase. The method is applied to a human bile sample and shows excellent resolution of the dihydroxy bile acid phenacyl esters. Detection limits for pure derivatized bile acids are 10–20 pmol (5–10 ng), except for the cholic acid derivative, which has a detection limit of 265 pmol.
Archive | 1978
Peter D. Klein; David L. Hachey; Mary Jeanne Kreek; D. A. Schoeller
The renaissance of interest in stable isotopes of hydrogen, carbon, nitrogen, oxygen and sulphur within the last ten years is based upon the development of new instrumentation, on the greater availability of enriched isotopes and on an espousal of non-radioactive techniques for human studies on ethical grounds. In order to put the present use of stable isotopes into perspective, we should examine both its antecedents and its expectations, so that we can judge the benefits to be expected.
Journal of Lipid Research | 1977
Kou-Yi Tserng; David L. Hachey; Peter D. Klein
Journal of Pharmaceutical Sciences | 1982
K. Nakamura; M.J. Kreek; Charles S. Irving; Peter D. Klein; David L. Hachey
Journal of Pharmaceutical Sciences | 1977
David L. Hachey; Mary Jeanne Kreek; D.H. Mattson
Journal of Labelled Compounds and Radiopharmaceuticals | 1973
David L. Hachey; Patricia A. Szczepanik; O. W. Berngruber; Peter D. Klein
Journal of Lipid Research | 1978
Patricia A. Szczepanik; David L. Hachey; Peter D. Klein
Archive | 1991
Heiner K. Berthold; David L. Hachey; Peter J. Reeds; Olivier P. Thomas; Scot Hoeksema; Peter D. Klein
Archive | 1976
Peter D. Klein; Patricia A. Szczepanik; David L. Hachey; Dale A. Schoeller